Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Your Profile Become a Member Log In Contact Us Get Newsletter
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
The Schizophrenia Research Forum web site is sponsored by NARSAD, the Mental Health Research Association, and supported in part by a contract from the National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services
Search Grants
Updated 13 May 2008
Government  
Sponsor:  
Non-Government  
Sponsor:  
Award:   Min.:     Max.:
Application Deadline:   Jan - Mar    Apr - Jun    Jul - Sep    Oct - Dec
 
Keyword:  
Grants – Most Recently Added and Modified
or
1 to 10 of 10 results
Program:Mouse Models Containing Human Alleles: Novel Tools to Study Brain Function (R21/R33)
Sponsor(s): National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institute on Aging
Details: This Funding Opportunity Announcement (FOA) invites Phased Innovation (R21/R33) grant applications from organizations /institutions that propose the development and characterization of novel mouse models that express human genes or human genetic elements that can aid in understanding the molecular mechanisms underlying brain function and the physiological function/significance of gene variants and gene dosage abnormalities that have been identified as possibly being involved in mental disorders, addiction, neurodegenerative disorders of aging, and alcoholism as well as related comorbid conditions
Deadline(s): June 26, 2008; January 28, 2009; May 28, 2009; January 28, 2010; May 28, 2010; January 28, 2011; letter of intent 30 days before deadline.
Program:Pharmacologic Agents and Drugs for Mental Disorders (SBIR R43/R44 [STTR R41/R42/])
Sponsor(s): National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
Details: This funding opportunity announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications that propose to develop novel pharmacologic agents for brain research related to mental disorders, including research aimed at discovering new drugs for these disorders. In addition, this FOA solicits SBIR grant applications that propose to take existing, promising compounds through the next step of drug discovery and development. Finally, this FOA also encourages SBIR grant applications designed to study the effectiveness of novel interventions.
Deadline(s): Opening date: July 5, 2008; Deadlines: August 5, December 5, April 5
Program:Lab to Marketplace: Tools for Brain and Behavioral Research (SBIR [R43/R44])
Sponsor(s): National Institutes of Health (NIH)
Details: This Funding Opportunity Announcement (FOA) encourages the translation of technologies for biomedical or behavioral research from academic and other non-small business research sectors to the marketplace. Small Business Concerns (SBCs) are encouraged to submit Small Business Innovation Research (SBIR) grant applications that propose to further develop, make more robust, and make more user-friendly such technologies in preparation for commercial dissemination. It is expected that this activity will require partnerships and close collaboration between the original developers of these technologies and SBCs, which may be accomplished in any of a number of ways, including the use of multiple principle investigators.
Deadline(s): Opening date: July 5, 2008; Deadlines: August 5, December 5, April 5
Program:2008 NIH Director’s New Innovator Award Program (DP2)
Sponsor(s): National Institutes of Health (NIH)
Details: The NIH Director’s New Innovator Award was created in 2007 to support a small number of new investigators of exceptional creativity who propose bold and highly innovative new research approaches that have the potential to produce a major impact on broad, important problems in biomedical and behavioral research. The research proposed need not be in a conventional biomedical or behavioral discipline but must be relevant to the mission of NIH. It is anticipated that up to 24 awards will be made in 2008. Awards are for five years.
Deadline(s): March 31, 2008
Program:Brain Disorders in the Developing World: Research Across the Lifespan (R01)
Sponsor(s): National Institutes of Health (NIH)
Fogarty International Center
Autism Speaks
Details: This Funding Opportunity Announcement (FOA) encourages grant applications proposing the development and conduct of innovative, collaborative research and research training projects, between High Income country (HIC) and low- to middle-income country (LMIC) scientists, on nervous system function and disorders throughout life, relevant to LMICs. The collaborative research programs are expected to contribute to the long-term goals of building sustainable research capacity in LMICs to address nervous system development, function and impairment throughout life and to lead to diagnostics, treatment and prevention strategies that are applicable worldwide. This FOA runs in parallel with an FOA of identical scientific scope, PAR-08-113, that encourages applications under the Exploratory/Developmental Grant (R21) award mechanism.
Deadline(s): May 16, 2008; May 15, 2009; May 14, 2010
Program:Data Deposition and Analyses of Genome Wide Association Studies of Mental Disorders (R01)
Sponsor(s): National Institutes of Health (NIH)
National Institute of Mental Health (NIMH)
Details: # The National Institute of Mental Health (NIMH) announces a limited competition for applications that propose to deposit data (genotypes and phenotypes) into an NIH Repository to augment existing resources and to analyze combined Genome Wide Association Studies (GWAS) of Mental Disorders of interest to the NIMH. This funding opportunity runs in parallel with a FOA of identical scientific scope, RFA-MH-08-121, that solicits applications under the Collaborative R01 mechanism.
Program:Treatment Trials for Schizophrenia and Bipolar Disorder
Sponsor(s): Stanley Medical Research Institute
Details: The purpose of this program is to facilitate the direct testing of new treatments for schizophrenia and bipolar disorder. The awards are granted for a maximum of $300,000 per year for up to three years, depending on the stage of development of the compounds to be tested and the type of trial that is required.
Deadline(s): October 1
Program:Sloan Research Fellowships
Sponsor(s): Alfred P. Sloan Foundation
Details: Flexible 2-year funding of $45,000 for early-career researchers. Must be nominated by department head or other senior researcher.
Deadline(s): Nominations due September 15.
Program:Sigma Delta Epsilon-Graduate Women in Science Fellowships
Sponsor(s): Sigma Delta Epsilon-Graduate Women in Science
Details: Various fellowships available, in all areas of natural science, for $5,000-$10,000. Applicants must be members of SDE/GWIS. See website for details.
Deadline(s): January 15
Program:SRMI Research Grants for Schizophrenia and Bipolar Disorder
Sponsor(s): Stanley Medical Research Institute
Details: See website for details.
Deadline(s): March 1
1 to 10 of 10 results
SRF Calendar

Submit your comments to our Forum Discussion: Disease Progression in Schizophrenia
Copyright © 2005- 2008 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright